Heritage Trust Co reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 26,077 shares of the healthcare conglomerate’s stock after selling 379 shares during the quarter. UnitedHealth Group makes up 1.5% of Heritage Trust Co’s investment portfolio, making the stock its 14th largest holding. Heritage Trust Co’s holdings in UnitedHealth Group were worth $9,702,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at $3,397,896,000. Viking Global Investors LP bought a new stake in UnitedHealth Group in the 4th quarter valued at $979,682,000. Price T Rowe Associates Inc. MD boosted its holdings in UnitedHealth Group by 5.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock valued at $13,318,678,000 after purchasing an additional 1,881,407 shares during the period. Fiera Capital Corp lifted its holdings in shares of UnitedHealth Group by 99.5% during the 1st quarter. Fiera Capital Corp now owns 2,137,018 shares of the healthcare conglomerate’s stock worth $795,120,000 after acquiring an additional 1,065,868 shares during the period. Finally, Morgan Stanley lifted its holdings in shares of UnitedHealth Group by 14.1% during the 4th quarter. Morgan Stanley now owns 7,989,764 shares of the healthcare conglomerate’s stock worth $2,801,850,000 after acquiring an additional 986,472 shares during the period. 86.23% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have recently commented on the stock. Oppenheimer raised their price objective on shares of UnitedHealth Group from $375.00 to $440.00 and gave the stock an “outperform” rating in a report on Friday, April 16th. Mizuho increased their target price on shares of UnitedHealth Group from $394.00 to $455.00 and gave the stock a “buy” rating in a research report on Friday, May 7th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $462.00 to $515.00 and gave the stock an “overweight” rating in a research report on Friday, April 16th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $409.00 to $418.00 and gave the stock a “buy” rating in a research report on Friday, April 16th. Finally, Truist increased their target price on shares of UnitedHealth Group from $420.00 to $450.00 in a research report on Wednesday, April 14th. Three research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $425.14.
UNH traded down $5.31 during trading on Friday, reaching $396.18. The company had a trading volume of 90,340 shares, compared to its average volume of 3,098,178. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.74 and a current ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $273.71 and a 12 month high of $425.98. The company’s fifty day moving average price is $399.21. The stock has a market capitalization of $373.88 billion, a P/E ratio of 22.82, a P/E/G ratio of 1.73 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $4.38 by $0.93. UnitedHealth Group had a net margin of 6.42% and a return on equity of 26.04%. The firm had revenue of $70.20 billion for the quarter, compared to analyst estimates of $69.13 billion. During the same quarter in the previous year, the firm posted $3.72 earnings per share. The business’s revenue was up 9.0% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 18.55 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 29th. Shareholders of record on Monday, June 21st will be paid a $1.45 dividend. The ex-dividend date of this dividend is Friday, June 18th. This represents a $5.80 dividend on an annualized basis and a yield of 1.46%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.25. UnitedHealth Group’s payout ratio is presently 29.62%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Recommended Story: Penny Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.